During the past decade, Hemophilia Ctr of Western PA / Univ of Pittsburgh conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hemophilia Ctr of Western PA / Univ of Pittsburgh" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "Health Resources and Services Administration (HRSA)" with 2 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hemophilia Ctr of Western PA / Univ of Pittsburgh" are "HIV Infections" (7 trials), "Hemophilia A" (1 trials), "Hemophilia A With Inhibitor" (1 trials), "Hemophilia A Without Inhibitor" (1 trials) and "Von Willebrand Diseases" (1 trials). Many other conditions were trialed in "Hemophilia Ctr of Western PA / Univ of Pittsburgh" in a lesser frequency.

Most popular intervention types in "Hemophilia Ctr of Western PA / Univ of Pittsburgh" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (6 trials), "Didanosine" (4 trials), "Eloctate ITI" (1 trials), "Eloctate Injectable Product" (1 trials) and "Emicizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hemophilia Ctr of Western PA / Univ of Pittsburgh" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hemophilia Ctr of Western PA / Univ of Pittsburgh". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hemophilia Ctr of Western PA / Univ of Pittsburgh, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hemophilia Ctr of Western PA / Univ of Pittsburgh, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".